Canonically the oncogenic kinase AKT is activated by growth signals. Our work suggests apoptotic materials, abundant in tumors, also contribute to AKT activation by stimulating MERTK that in turn phosphorylates Y26 in the AKT PH domain. pY26 reverses binding of an AKT endogenous, WW-domain containing inhibitor, SAV1, allowing AKT responsiveness to classic growth signals. This novel mechanism may contribute to drug resistance.
CITATION STYLE
Zhang, Y., Earp, H. S., & Liu, P. (2019, July 4). Beyond growth signaling: apoptotic sensor MERTK activates AKT by a novel mechanism. Molecular and Cellular Oncology. Taylor and Francis Ltd. https://doi.org/10.1080/23723556.2019.1611161
Mendeley helps you to discover research relevant for your work.